Psoriatic Arthritis Recommendations - GRAPPA

Psoriatic Arthritis GRAPPA

GRAPPA Psoriatic Arthritis App brought to you free of charge courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/662287

Contents of this Issue

Navigation

Page 13 of 15

12 Treatment Table 11. Considerations for Treatment of Patients with Psoriatic Arthritis and Concomitant Comorbidities Comorbidity Non-steroidal Anti-inflammatory Drugs Glucocorticoids Hydroxychloroquine Sulfasalazine Methotrexate Leflunomide Cyclosporine Cardiovascular Disease C ? Congestive Heart Failure C C Obesity C Metabolic Syndrome C C Diabetes C C Ulcerative Colitis ? A OL Crohn's Disease ? A OL Uveitis P b Osteoporosis C Malignancy Fatty Liver Disease C C C C Chronic Kidney Disease C C ? SM Depression Chronic Hepatitis B a C C C Chronic Hepatitis C a C C C Human Immunodeficiency Virus A = Approved for primary therapy of the comorbid condition C = Reason for caution OL = Off-label use for the therapy of the comorbid condition P = Preferred therapy SM = Requires special monitoring ? = Data insufficient but concerns have been raised Blank box = No information available

Articles in this issue

view archives of Psoriatic Arthritis Recommendations - GRAPPA - Psoriatic Arthritis GRAPPA